Publication | Closed Access

Selection of resistant acute myeloid leukemia SKM-1 and MOLM-13 cells by vincristine-, mitoxantrone- and lenalidomide-induced upregulation of P-glycoprotein activity and downregulation of CD33 cell surface exposure

Hematological MalignancyMolm-13 CellsLenalidomide-induced UpregulationMedicineMixed-phenotype Acute LeukemiaMalignant Blood DisorderImmunologyHematologyAnti-cancer AgentImmunotherapyPharmacologyTumor MicroenvironmentP-glycoprotein ActivityMyeloid Neoplasia